Status:

UNKNOWN

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)

Lead Sponsor:

University of Sussex

Collaborating Sponsors:

Brighton and Sussex University Hospitals NHS Trust

Conditions:

HIV Infections

Eligibility:

All Genders

18+ years

Brief Summary

Improvements in health care and antiretroviral treatments have made it possible to turn HIV into a chronic disease leading to longer life expectancies and better quality of life among patients. Dual-d...

Detailed Description

The investigators propose a three-phase comparative study with a control population (i.e., people living with HIV on other dual therapy regimens and triple ART) and the target population (i.e., people...

Eligibility Criteria

Inclusion

  • Adults (aged 18 years old or older)
  • Able to consent
  • Receive HIV care at the HIV Department of the Brighton and Sussex University Hospital (Lawson Unit/Elton John Centre)
  • All genders, sexual orientations, and socio-economic groups are eligible for participation
  • On one of the following therapies
  • Control population
  • Juluca (DTG/rilpivirine\[RPV\])
  • Boosted darunavir plus lamivudine (DRV/r or DRV/c + 3TC)
  • Boosted darunavir plus raltegravir (DRV/r or DRV/c + RAL)
  • A triple regimen (2 nucleos(t)ide reverse transcriptase inhibitors \[NRTIs\] + 1 InSTI; 2 NRTIs + 1 non-nucleoside reverse transcriptase inhibitor \[NNRTI\]; 2 NRTIs + boosted protease inhibitor \[PI/b\])
  • Target population
  • DTG/3TC

Exclusion

  • Patients taking off-label drug combinations due to complex HIV resistance patterns.
  • ART naïve or individuals declining ART will be excluded.
  • Patients without access to the technology to participate in the online study will be given the option to participate in person (following COVID-19 guidance), and if this is not possible they will be excluded.

Key Trial Info

Start Date :

July 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 30 2022

Estimated Enrollment :

118 Patients enrolled

Trial Details

Trial ID

NCT04901728

Start Date

July 1 2021

End Date

July 30 2022

Last Update

May 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Sussex County Hospital, Brighton, UK

Brighton, United Kingdom, BN2 5BE